SCHEMBL30209124

SCHEMBL30209124

CC(C)c1cnn2c(NCc3ccccc3N(C)C)cc(Cl)nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 9/20 0.53
▸ CCNE1 P24864 8/20 0.53
▸ CDK9 P50750 5/20 0.53
▸ CDK7 P50613 16/20 0.50
▸ CCNH P51946 7/20 0.46
▸ CDK1 P06493 6/20 0.46
▸ MNAT1 P51948 6/20 0.46
▸ CDK4 P11802 4/20 0.46
▸ CDK6 Q00534 4/20 0.46
▸ CDK5 Q00535 4/20 0.46
▸ CDK8 P49336 3/20 0.46
▸ CCNT1 O60563 2/20 0.46
▸ CCNB1 P14635 2/20 0.46
▸ CCND1 P24385 2/20 0.46
▸ CDK5R1 Q15078 1/20 0.46
▸ INSRR P14616 1/20 0.45
▸ MAPK3 P27361 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ CSNK1A1 P48729 1/20 0.45
▸ DYRK1A Q13627 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24963424 1.00 CDK2 (0.53) CDK2CCNE1CDK9CDK7CCNH
SCHEMBL1368924 0.85 CDK7 (0.67) CDK2CCNE1CDK9CDK7CCNH
SCHEMBL24962497 0.85 CDK7 (0.46) CDK2CCNE1CDK9CDK7CCNH
SCHEMBL30209116 0.84 CDK7 (0.51) CDK2CCNE1CDK9CDK7CCNH
SCHEMBL24962532 0.84 CDK7 (0.51) CDK2CCNE1CDK9CDK7CCNH
SCHEMBL24963255 0.82 CDK7 (0.42) CDK2CCNE1CDK9CDK7CCNH
SCHEMBL30209128 0.82 CDK7 (0.42) CDK2CCNE1CDK9CDK7CCNH
SCHEMBL30209126 0.82 CDK7 (0.42) CDK2CCNE1CDK9CDK7CCNH
SCHEMBL1370667 0.82 CDK7 (0.66) CDK2CCNE1CDK9CDK7CCNH
SCHEMBL12143379 0.80 CDK7 (0.46) CDK2CCNE1CDK9CDK7CCNH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023001061-A1 CDK7 SELECTIVE INHIBITORS AS ANTICANCER AGENTS JINGRUI BIOPHARMA CO., LTD. (CN) 2023-01-26 — — WO disclosed
Send feedback